More on SHPGY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.2 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SHPGY Cash Flow Statement

Click line-items for a historical chart and %
Net income
Depreciation and amortization 877.8M
Share based compensation 269.6M
Gain on sale of non-current investments
Other
Movement in deferred taxes -546.9M
Equity in earnings of equity method investees
Loss/(gain) on sale of product rights
Increase in accounts receivable -411.2M
Increase in sales deduction accrual 108.2M
Increase in inventory -228M
Increase in prepayments and other assets -66.4M
Decrease in accounts payable and other liabilities 315.2M
Net cash provided by operating activities 1.51B
Movements in restricted cash 68.3M
Purchases of subsidiary undertakings, net of cash acquired -17.48B
Purchases of non-current investments -402.5M
Purchases of property, plant and equipment ("PP&E")
Purchases of intangible assets
Proceeds from disposal of non-current investments, PP&E and product rights 600K
Returns of equity investments and proceeds from short term investments
Net cash used in investing activities -17.81B
Proceeds from drawings of revolving credit facility 31.74B
Repayment of debt acquired with ABH -14.63B
Payment under building finance obligation
Extinguishment of building finance obligation
Tax benefit of stock based compensation
Proceeds from exercise of options 98.9M
Payment of dividend -130.2M
Payments to acquire shares by ESOT
Net cash used in financing activities 16.9B
Net (decrease)/increase in cash and cash equivalents 593.1M
Effect of foreign exchange rate changes on cash and cash equivalents -2.2M
Cash and cash equivalents at beginning of period 135.5M
Cash and cash equivalents at end of period 728.6M
Interest paid 223.4M
Income taxes paid 355.8M
Equity in Vertex Pharmaceuticals, Inc. ("Vertex") received as part consideration for disposal of non-current investment

Entities mentioned with SHPGY

View All Entities